PROJECT: This survey is conducted by the Institute of Health Policy & Management (iBMG) of the Erasmus University of Rotterdam, The Netherlands, as part of the EU funded Horizon 2020 project which aims at developing and validating a new imaging technology called Spectral Photon Counting CT (SPCCT) and contrast media. SPCCT will allow earlier diagnosis by means of a high spatial resolution combined to the newly developed contrast agent.The project website can be found at the following URL: http://www.spcct.eu/
RATIONALE: There is a need to assess the current local clinical practice in order to evaluate the cost-effectiveness of the SPCCT-based strategy for diagnosing and treating stroke patients in different European countries.
GOAL: This clinician survey is meant to assess the current diagnosis and treatment patterns of acute stroke patients in European countries.
TARGET: The survey is targeted at neurologists, stroke physicians, neurointerventionalists, neuroradiologists, neurosurgeons and emergency physicians (including those completing their specialisation).
RESULTS: The results will be analyzed, reported to the European Commission and shared via a publication in a scientific journal. The responses to the survey will be collected anonymously, individual information will not be used for commercial purposes or transferred to other third parties and any information you provide will be kept strictly confidential. Only if you wish to be involved in a subsequent phase of the SPCCT project, you will be given the opportunity to provide your email address.
NEED HELP? If you need some help or extra explanation, you can send an email to firstname.lastname@example.org. We will reply to your email as soon as possible. We highly appreciate your time and collaboration and thank you for answering this survey.
Anne-Claire PEULTIER, PhD candidate Ken REDEKOP, PhD, clinical epidemiologist and associate Professor of health technology assessmentHans SEVERENS, PhD, Professor of health technology assessment